Literature DB >> 3305117

Colloidal bismuth subcitrate in peptic ulcer--a review.

G N Tytgat.   

Abstract

De-Nol (colloidal bismuth subcitrate, CBS) precipitates in an acid environment and adheres to the exudate layer covering an ulcer crater; moreover, CBS blocks pepsin activity, retards hydrogen-ion back-diffusion and stimulates prostaglandin synthesis. The average healing rate in duodenal ulcer (DU) after 4 weeks' treatment with CBS is 78% versus 63% with cimetidine. In a direct comparison, CBS gives 84% healing as opposed to 78% with ranitidine. The average healing rate after 4 weeks' treatment with CBS in gastric ulcer (GU) is 68% compared to 54% with cimetidine. The percentage of relapse-free patients, 1 year after DU or GU healing, with CBS is substantially higher than is the case with H2-receptor blockers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305117     DOI: 10.1159/000199556

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.

Authors:  Quan Zhou; Zou-Rong Ruan; Hong Yuan; Bo Jiang; Dong-Hang Xu
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

2.  Effect of repeated colloidal bismuth subcitrate treatment on the response of the rat gastric mucosa to the presence of luminal ethanol.

Authors:  S M Hinsull; D Bellamy
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

Review 3.  Formulary management of antiulcer drugs: clinical considerations.

Authors:  S L Sankey; L S Friedman
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

4.  Mechanism of action of nonantisecretory agents.

Authors:  J De Wal
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

5.  Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques.

Authors:  P E O'Brien; G Frydman; R Holmes; C Malcontenti; D Phelan
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 6.  Helicobacter pylori: bridging the credibility gap.

Authors:  A W McKinlay; R Upadhyay; C G Gemmell; R I Russell
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

7.  Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat.

Authors:  S M Hinsull
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

8.  Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity.

Authors:  G S Sandha; R LeBlanc; S J Van Zanten; T D Sitland; L Agocs; N Burford; L Best; D Mahoney; P Hoffman; D J Leddin
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

9.  Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.

Authors:  S Wagner; M Gebel; K Haruma; W Bär; P Lange; J Freise; U Gladziwa; F W Schmidt
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.